Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 devel...
Q2 2026
Aug 5, 2026
Q1 2026
May 6, 2026
FY 2025
Feb 11, 2026
Q4 2025
Q3 2025
Nov 5, 2025